As a biotech company with a global perspective and a focus on innovation, we actively seek stategic partners to expand BJ Bioscience's product pipeline worldwide.
Out-license or co-development:
All of our products are discovered internally with global IP rights. We are willing to discuss potential mutually beneficial cooperation with overseas with all potential partners
BJ Bioscience has a rich and balanced pipeline. Many of our products have potential to combine with other drugs for better efficacy or lower toxicity. We are willing to explore potential combination treatment with all therapeutics including but not limited to IO drugs, targeted therapeutics and traditional chemotherapeutic drugs
Besides internal discovery and innovation, we are open to collaborate with innovators from universities, research institutes and other biotechnology company as the company continues to grow.